Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Galstyan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2023
β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse modelsLiron L Israel, Tao Sun, Oliver Braubach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2016
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiformeSzu-Ting Chou, Rameshwar Patil, Anna Galstyan, et al.
Neurobiology of Disease|September 22, 2023
Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse studyLiron L Israel, Oliver Braubach, Ekaterina S Shatalova, et al.
Nature Communications|February 1, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Nature Communications|August 30, 2019
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Nature Communications|November 27, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Cancer Research|January 20, 2019
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talkTao Sun, Rameshwar Patil, Anna Galstyan, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 23, 2020
Cranial and ventricular size following shunting or endoscopic third ventriculostomy (ETV) in infants with aqueductal stenosis: further insights from the International Infant Hydrocephalus Study (IIHS)Ian C Coulter, Abhaya V Kulkarni, Spyros Sgouros, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2023
β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse modelsLiron L Israel, Tao Sun, Oliver Braubach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2016
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiformeSzu-Ting Chou, Rameshwar Patil, Anna Galstyan, et al.
Neurobiology of Disease|September 22, 2023
Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse studyLiron L Israel, Oliver Braubach, Ekaterina S Shatalova, et al.
Nature Communications|February 1, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Nature Communications|August 30, 2019
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Nature Communications|November 27, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.
Cancer Research|January 20, 2019
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talkTao Sun, Rameshwar Patil, Anna Galstyan, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 23, 2020
Cranial and ventricular size following shunting or endoscopic third ventriculostomy (ETV) in infants with aqueductal stenosis: further insights from the International Infant Hydrocephalus Study (IIHS)Ian C Coulter, Abhaya V Kulkarni, Spyros Sgouros, et al.
Pageof 2